Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025
Inside the Oversight Gap: How Telehealth Escapes FDA Rules These products bypass traditional insurance and reimbursement pathways, enabling direct-to-consumer sales that look more like e-commerce than clinical care
This sustained release ensures that the peptides remain active on your skin for several hours, promoting continuous healing and collagen production
1 cause of maternal death in the United States, according to the Centers for Disease Control and Prevention
Cannot redeclare control with same name "grid_6_qv_cta_typography_line_height"